Recent advances in gene therapy for atrial fibrillation.
Atrial fibrillation (AF) is the most common heart rhythm disorder in adults and a major cause of stroke. Unfortunately, current treatments for AF are suboptimal as they are not targeting the molecular mechanisms underlying AF. In this regard, gene therapy is emerging as a promising approach for mechanism-based treatment of AF. In this review, we summarize recent advances and challenges in gene therapy for this important cardiovascular disease.
['Yoo|Shin|S|0000-0002-7412-3260', 'Geist|Gail Elizabeth|GE|', 'Pfenniger|Anna|A|0000-0001-7812-0860', 'Rottmann|Markus|M|', 'Arora|Rishi|R|0000-0002-0725-4332']
D000328:Adult D001281:Atrial Fibrillation D015316:Genetic Therapy D006801:Humans D020521:Stroke
gene therapy atrial fibrillation